Chargement de la fiche…
Chargement de la fiche…
rhumatologie
Praticien hospitalier
Paris 13e Arrondissement (75651)
Rheumatoid Arthritis Research and Therapies · Spondyloarthritis Studies and Treatments · Autoimmune and Inflammatory Disorders Research
Tout est calculé à partir des sources publiques (RPPS, PubMed, OpenAlex, OpenStreetMap…) — aucun classement éditorial.
2025
International University of Monaco
2023
University of Padua
2023
University of Lisbon
2023
University of Ljubljana
2021
Innsbruck Medical University
2017
University of British Columbia
0
h-index
0
i10
0
citations
Le h-index mesure la productivité scientifique : ce médecin a publié 71 articles cités au moins 71fois par d'autres chercheurs. Plus c'est élevé, plus son travail influence la communauté médicale.
Côté patient
Comprendre votre pathologie, exercices à domicile, applications validées, paramédicaux à proximité — gratuit, sans inscription.
DES Rhumatologie · Rhumatologie (SM) — Diplôme d'Études Spécialisées
DE Docteur en médecine — Capacité / Certificat d'Études Spéciales
0
travaux
0
h-index
0
i10-index
0
citations
2026Joint bone spine
PubMed ↗Health care practices in symptomatic knee and hip osteoarthritis patients: The KHOALA cohort
2026Joint bone spine
PubMed ↗Association between rheumatoid arthritis flares and joint structural changes at 24 months: using FLARE-RA questionnaire
2026Annals of the rheumatic diseases
PubMed ↗EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update
2026Joint bone spine
PubMed ↗Treatment sequences of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis: A nationwide population-based study in France
2026Nature communications
PubMed ↗Adult patients with autoinflammation of unknown origin partially phenocopy the immune presentation of Still's disease
2026Joint bone spine
PubMed ↗Baseline characteristics of the TRANSLATE2 cohort: A prospective study on rheumatoid arthritis-associated interstitial lung disease
2025RMD open
PubMed ↗Adaptive immune responses to SARS-CoV-2 in DMARD-treated patients with chronic inflammatory rheumatisms
2025RMD open
PubMed ↗Cluster analysis identifies three clinical patterns of patients with systemic autoimmune diseases and anti-Ku antibodies
2025Scandinavian journal of rheumatology
PubMed ↗Global health in axial spondyloarthritis: thresholds for the Assessment of SpondyloArthritis international Society Health Index and the EuroQol score: analysis of the ASAS-PerSpA study
2025Osteoarthritis and cartilage open
PubMed ↗Metabolic syndrome is associated with more pain in hand osteoarthritis: Results from the DIGICOD cohort
2025Joint bone spine
PubMed ↗Factors associated with dietary practices and beliefs on food of patients with rheumatic and musculoskeletal diseases: A multicentre cross-sectional study
2025Annals of the rheumatic diseases
PubMed ↗Response to correspondence on 'Pulmonary arterial hypertension in adults with Still's disease: another pulmonary manifestation associated with HLA-DRB1*15' by Boucly A, et al
2025Annals of the rheumatic diseases
PubMed ↗Response to correspondence on: Pulmonary arterial hypertension in adults with Still's disease: another pulmonary manifestation associated with HLA-DRB1*15
2025Osteoarthritis and cartilage open
PubMed ↗Association between weather features and symptoms in hand osteoarthritis: Results from the DIGICOD cohort
2025Osteoarthritis and cartilage open
PubMed ↗Greater pain and functional impairment in chronic erosive hand osteoarthritis compared to treated rheumatoid arthritis: A comparative study
2025Annals of the rheumatic diseases
PubMed ↗Pulmonary arterial hypertension in adults with Still's disease: another pulmonary manifestation associated with HLA-DRB1*15
2025The Lancet. Rheumatology
PubMed ↗The use of IL-1 and IL-6 inhibitors should be prioritised in Still's disease
2025European journal of internal medicine
PubMed ↗Serum interleukin-18 levels are specifically elevated in auto-inflammatory diseases involving the pyrin inflammasome: A study on 516 patients
2025Rheumatology (Oxford, England)
PubMed ↗Exposure during pregnancy to Il-1 targeted therapies and pregnancy, foetal and neonatal outcomes: a study from the French Teratology Information Service
2024Journal of clinical epidemiology
PubMed ↗The Flare-OA-16 questionnaire measuring flare in knee and hip osteoarthritis in the patient perspective: scale reduction and validation using a Rasch model
2024Clinical and experimental rheumatology
PubMed ↗Comparison of SARS-COV-2 humoral response between rheumatoid arthritis, psoriatic arthritis and spondyloarthritis patients and controls in two unvaccinated cohorts
2024Joint bone spine
PubMed ↗2024 update of the recommendations of the French Society of Rheumatology for the diagnosis and management of patients with rheumatoid arthritis
2026RMD open
PubMed ↗Effects of upadacitinib or adalimumab on pain in rheumatoid arthritis and psoriatic arthritis: results from randomised phase 3 studies
2025Rheumatology (Oxford, England)
PubMed ↗Do SMS/e-mail reminders increase influenza vaccination of rheumatoid arthritis patients under anti-TNF: a nested randomized controlled trial in the ART e-cohort
2025Drugs - real world outcomes
PubMed ↗Correction: Real-World Evidence of Clinical Outcomes of the Use of the Adalimumab Biosimilar SB5 in Rheumatic and Gastrointestinal Immune-Mediated Inflammatory Diseases: 12-Month Data from the PERFUSE Study
2025Advances in therapy
PubMed ↗Real-World Effectiveness and Safety of Infliximab Biosimilar CT-P13 for Rheumatic Diseases: A National Observational Cohort Study (ReFLECT)
2024Drugs - real world outcomes
PubMed ↗Real-World Evidence of Clinical Outcomes of the Use of the Adalimumab Biosimilar SB5 in Rheumatic and Gastrointestinal Immune-Mediated Inflammatory Diseases: 12-Month Data from the PERFUSE Study
2025La Revue de medecine interne
PubMed ↗French protocol for the diagnosis and management of juvenile idiopathic arthritis including pediatric-onset Still's disease
2025Joint bone spine
PubMed ↗Systemic juvenile idiopathic arthritis and adult-onset Still's disease are the same disease and should now be designated by the same unique name, Still's disease
2024Annals of the rheumatic diseases
PubMed ↗EULAR/PReS recommendations for the diagnosis and management of Still's disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still's disease
2024Annals of the rheumatic diseases
PubMed ↗Systemic juvenile idiopathic arthritis and adult-onset Still's disease are the same disease: evidence from systematic reviews and meta-analyses informing the 2023 EULAR/PReS recommendations for the diagnosis and management of Still's disease
2026Joint bone spine
PubMed ↗Social and occupational factors are associated with musculoskeletal pain prevalence in the general population: A population-based cohort study
2026The Lancet. Rheumatology
PubMed ↗Development and validation of clinical criteria for the definition of disease activity in adult-onset Still's disease: a cohort study
2026Joint bone spine
PubMed ↗AA amyloidosis in inflammatory joint diseases in the era of biological therapies: Prevalence, manifestations, management and evolution
2025Joint bone spine
PubMed ↗Diseases associated with anti-centromere protein F (anti-CENP-F) antibodies: Insights from a large cohort study
2025Arthritis & rheumatology (Hoboken, N.J.)
PubMed ↗Maintenance of Remission After Tocilizumab Withdrawal in Patients With Glucocorticoid-Dependent Polymyalgia Rheumatica
2025Frontiers in medicine
PubMed ↗Long-term management of elderly patients with rheumatoid arthritis treated with tocilizumab: comparison of patients over and under 75 years old
2025BMJ open
PubMed ↗Abatacept versus tocilizumab for the treatment of rheumatoid arthritis in TNF inhibitor inadequate responders: study protocol of the SUNSTAR randomised controlled open-label superiority trial
2026Rheumatology and therapy
PubMed ↗Correction to: Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observational RA-BE-REAL Study in European Patients
2026RMD open
PubMed ↗Effects of upadacitinib or adalimumab on pain in rheumatoid arthritis and psoriatic arthritis: results from randomised phase 3 studies
2026Joint bone spine
PubMed ↗Impact of regulatory events on JAK inhibitor prescribing in rheumatoid arthritis: Insights from the French MAJIK Registry
2026Journal of Crohn's & colitis
PubMed ↗Safety of advanced therapies during pregnancy in women with immune-mediated inflammatory diseases: a systematic review and meta-analysis
2025Seminars in arthritis and rheumatism
PubMed ↗AA amyloidosis in inflammatory joint diseases: A systematic review
2024Annals of the rheumatic diseases
PubMed ↗Efficacy and safety of therapies for Still's disease and macrophage activation syndrome (MAS): a systematic review informing the EULAR/PReS guidelines for the management of Still's disease
2026Journal of Crohn's & colitis
PubMed ↗Safety of advanced therapies during pregnancy in women with immune-mediated inflammatory diseases: a systematic review and meta-analysis
2025Seminars in arthritis and rheumatism
PubMed ↗AA amyloidosis in inflammatory joint diseases: A systematic review
2024Annals of the rheumatic diseases
PubMed ↗Efficacy and safety of therapies for Still's disease and macrophage activation syndrome (MAS): a systematic review informing the EULAR/PReS guidelines for the management of Still's disease
2026Journal of back and musculoskeletal rehabilitation
PubMed ↗Biopsychosocial phenotyping of patients with chronic low back pain using the pain and disability drivers management model: A retrospective cohort study
2025Joint bone spine
PubMed ↗Predictors of return to work after multidisciplinary rehabilitation program for patients with chronic low back pain
2026Journal of Crohn's & colitis
PubMed ↗Safety of advanced therapies during pregnancy in women with immune-mediated inflammatory diseases: a systematic review and meta-analysis
2024Annals of the rheumatic diseases
PubMed ↗Efficacy and safety of therapies for Still's disease and macrophage activation syndrome (MAS): a systematic review informing the EULAR/PReS guidelines for the management of Still's disease
2025The Lancet. Rheumatology
PubMed ↗Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trial
2026Arthritis & rheumatology (Hoboken, N.J.)
PubMed ↗A Multifaceted Interplay Among Hemophagocytosis, Interleukin-18, and Type I Interferon Distinguishes Still Disease From Other Autoinflammatory Diseases
2025Arthritis & rheumatology (Hoboken, N.J.)
PubMed ↗Characterization of Genetic Landscape and Novel Inflammatory Biomarkers in Patients With Adult-Onset Still's Disease
2025Rheumatology and therapy
PubMed ↗Association Between Patient-Reported Pain and Remission or Low Disease Activity in Patients with Rheumatoid Arthritis: Data from RA-BE-REAL Prospective Observational Study
2026Article
Club Rhumatismes et Inflammation guidelines for anti-interleukin-1 therapy: 2026 update
Joint Bone Spine
2026Article
Social and occupational factors are associated with musculoskeletal pain prevalence in the general population: a population-based cohort study
Joint Bone Spine
2026Article
Association between rheumatoid arthritis flares and joint structural changes at 24 months: using FLARE-RA questionnaire
Joint Bone Spine
2025Article
Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trial
The Lancet Rheumatology
2025Article
Maintenance of Remission After Tocilizumab Withdrawal in Patients With Glucocorticoid‐Dependent Polymyalgia Rheumatica
Arthritis & rheumatology
2025Article
Biopsychosocial phenotyping of patients with chronic low back pain using the pain and disability drivers management model: A retrospective cohort study
Journal of Back and Musculoskeletal Rehabilitation
2025Article
Exposure during pregnancy to Il-1 targeted therapies and pregnancy, foetal and neonatal outcomes: a study from the French Teratology Information Service
Rheumatology
2025Article
Adaptive immune responses to SARS-CoV-2 in DMARD-treated patients with chronic inflammatory rheumatisms
RMD Open
▶Activité physique et polyarthrite rhumatoïde
Société Française de Rhumatologie
▶05/03/2025 Les manifestations rhumatologiques du diabète Pr Bruno FAUTREL
COFER
▶Bruno FAUTREL - Maladie de Still : actualités bibliographiques 2023-2024
RESO Bordeaux
▶La douleur est-elle une fatalité ?
AFPric
▶Mal de dos, mal du siècle ?
Médecine TV
▶Le parcours de soins du patient
Polyarthrite Andar
Encadrement de doctorants — signal d'activité universitaire.